The Fresh Test™ is a diagnostic glucose beverage intended for gestational diabetes screening. Glucose tolerance tests are typically performed at 24-28 weeks gestation.
Fresh Test, LLC understands that there are many patients with allergies, intolerability issues and diet restrictions that prevent them from being able to consume other diagnostic glucose beverage brands. Fresh Test, LLC has invested in R&D to formulate an organic, high-quality and additive-free product that is known to increase screening adherence and also improve the patient’s experience of the OGTT.
If Fresh Test, LLC is new to your team; here are materials that can assist. Please reach out if you’d like a follow-up meeting or additional resources. We hope that The Fresh Test™ diagnostic glucose beverage line may soon become available in your community.
Distributors – The Fresh Test™ product line is available directly from our website or through Purchase Order. If your hospital prefers an established distributor, you are welcome to visit ThermoFisher who carries our glucose beverages. If you would like to be put in touch with the local ThermoFisher Account Executive, please email email@example.com otherwise please visit this website, ThermoFisher.
LabCorp– Visit LabCorp's Partners in Pregnancy™ for more information.
Although some LabCorp sites stock The Fresh Test™, it is more common that their providers stock the product via LabCorp's Wholesale Link.
This table offers the recommended guidelines as printed in the American Diabetes Association's 2022 Standards of Medical Care in Diabetes Journal. For up-to-date methods and thresholds please refer to ACOG, ADA, IADPSG, NDDG, or other accredited organizations. American Diabetes Association – Standards of Care in Diabetes, 2023 Screening for and diagnosis of GDM: One-step strategy and Two-step strategy; Page 41.
Disclaimer: The following are third-party resources and select publications available online. Articles were selected based on the useful applicability to glucose tolerance testing. These are not meant to be claims and are not intended as a product solicitation or promotion where such activities are prohibited. These resources are identified here to assist in education and communication of clinical and scientific evidence. The content on this site is for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis or treatment.
Cola, Confection, and Confusion: OGTT Alternatives for Gestational Diabetes
Available at CapTodayOnline, June 2010. Written by Kevin F. Foley PhD, DABCC and Shirley L. Welch, Phd, DABCC.
Toward Universal Criteria for Gestational Diabetes: The 75-gram Glucose Tolerance Test in Pregnancy
Available in AJOG, February 1995. Written by David Sacks MD, Jeffrey Greenspoon MD, Salim Abu-Fadil MD, Harold Henry MD, Girma Wolde-Tsadik PhD and Jannis F.F. Yao.
Reducing Prenatal Exposure to Toxic Environmental Agents
Available in ACOG, October 2013. Written by Nathaniel DeNicola MD, Ann Borders MD, Veena Singla PhD and Tracey Woodruff, PhD.
Combining HbA1c and Insulin Resistance to Assess the Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study
Available on PubMed, April 2023. Written by Yin Lijing Ding, Zhuopeng Chen, Yan Chen and Yuning Zhu.
American Diabetes Association: Standards of Medical Care in Diabetes - 2023.
Classification and Diagnosis of Diabetes. Page: S33 Table 2.7 – Screening for and diagnosis of GDM.
Available on ADA.com. References ACOG and Carpenter-Coustan criteria.
Effect of Glucose, Sucrose and Fructose on Plasma Glucose and Insulin Responses in Normal Humans: Comparison with White Bread
Available at PubMed, December 1998. Written by B M Lee and TM Wolever.
Continuous Glucose Monitoring Metrics for Earlier Idnetification of Pre-Diabetes: Protocol for a Systematic Review and Meta-Analysis
Available at BMJ Journals, 2022. Written by Sara Gottfried, Laura Pontiggia, Andrew Newberg, Gregory Laynor and Daniel Monti.